Plakous Therapeutics
PrivateLast Round
Grant
Dec 8, 2025
Total Funding Raised
$5.49M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Plakous Therapeutics is a biotechnology company that develops regenerative biotherapeutics derived from human placental extract to treat inflammation-driven diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Plakous Therapeutics Comparables
Compare Plakous Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Noveome Biotherapeutics | 82% | |
| Siolta Therapeutics | 81% | |
| Infant Bacterial Therapeutics | 77% |
Plakous Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 8, 2025 | ||||
| Series A | Oct 24, 2025 | ||||
| Grant | Oct 24, 2025 | ||||
| Grant | Jun 1, 2022 | ||||
| Debt | Jun 1, 2022 | ||||
Grant | Jul 8, 2020 |
Plakous Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| North Carolina Biotechnology Center | Debt |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors grew 50% MoM, reaching 2.5K.
- May 11, 2026
Monthly visitors grew 32% MoM.
Plakous Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Plakous Therapeutics's valuation, stock price, and market status.
Is Plakous Therapeutics a public or private company?
Plakous Therapeutics is a private company.
What is the current stock price of Plakous Therapeutics?
Plakous Therapeutics is a private company with no public stock price. Caplight tracks Plakous Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Plakous Therapeutics worth (valuation)?
Valuation information for Plakous Therapeutics is not publicly available.
Can I buy Plakous Therapeutics stock?
Plakous Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Plakous Therapeutics's last funding round?
Plakous Therapeutics's most recent funding round was Grant on December 8, 2025.
Who are the main investors in Plakous Therapeutics?
Key investors in Plakous Therapeutics include North Carolina Biotechnology Center, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Will Plakous Therapeutics IPO soon?
No public IPO plans have been announced for Plakous Therapeutics.
How can I track Plakous Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Plakous Therapeutics's secondary market activity and sign up for updates.